Search

Search Constraints

You searched for: Author/Creator Gebski, Val

Search Results

1. 204. THE TUMOUR IMMUNE MICROENVIRONMENT IN OESOPHAGEAL ADENOCARCINOMA HAS PROGNOSTIC SIGNIFICANCE. (24th September 2022)

2. 280. MULTI-OMIC FEATURES OF OESOPHAGEAL ADENOCARCINOMA PATIENTS PRE-TREATED WITH PREOPERATIVE NEOADJUVANT THERAPY. (24th September 2022)

3. A high-volume, low-cost approach to participant screening and enrolment: Experiences from the T4DM diabetes prevention trial. (December 2019)

6. Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup. Issue 8 (August 2022)

8. Combination chemotherapy with NAB®‐paclitaxel and capecitabine for patients with advanced biliary tract cancer (NAP‐CAPABIL Pilot Study). Issue 5 (28th June 2021)

9. COMmunication with Families regarding ORgan and Tissue donation after death in intensive care (COMFORT): protocol for an intervention study. Issue 1 (December 2017)

10. Concordance between CA-125 and RECIST progression in patients with germline BRCA-mutated platinum-sensitive relapsed ovarian cancer treated in the SOLO2 trial with olaparib as maintenance therapy after response to chemotherapy. (November 2020)